About Desh Rakshak
Desh Rakshak is a publicly listed company based in India. Ayurvedic product manufacturing and sales based in India. Its Indian entity Desh Rakshak Aushdhalaya Limited reported revenue of βΉ7.11 Cr. Desh Rakshak offers products and services including Ayurvedic Granules and Syrups and Tablets. Its focus areas include Wholesale and Distribution, Exports and Supplies, Government and Institutional Supplies and Pharmaceuticals.
Company details
Desh Rakshak is recognized as an established Ayurvedic brand that has been operated since 1901, offering a range of herbal products including granules, balms, tablets, and syrups. It is situated in Haridwar, India, where manufacturing and distribution processes are managed for both domestic and export markets. Products are supplied to government departments and individual customers, with quality ensured through natural ingredients and customer feedback. The company is noted for its historical significance in the region and commitment to Ayurvedic traditions, as evidenced by testimonials and online presence.
- Headquarters India
- Stage Public
- SectorsHealthcare
- Emailβ’β’β’β’β’β’β’β’
- Website deshrakshak.in
- Social LinkedIn X Instagram
- Legal Name Desh Rakshak Aushdhalaya Ltd.
- Market Cap₹13.96 Cr
DESHRAK · BSE
- Share Price₹24.50
0.00% today
- Revenue₹7.10 Cr
FY 2025-26 · +13.2% YoY
- EBITDA₹1.38 Cr
Margin 19.4%
- Net Profit₹0.56 Cr
FY 2025-26 · +21.7% YoY
- P/E (TTM)25.3x
P/B 1.1x
Associated legal entities of Desh Rakshak
Desh Rakshak operates through Desh Rakshak Aushdhalaya Limited, a listed company (active). Its filings, financials, charges and directors are on the company page.
| Legal entity | Status | Incorporated | Registered in | Revenue (FY 2026) | Employees | Directors | Company page |
|---|---|---|---|---|---|---|---|
| Desh Rakshak Aushdhalaya Limited Listed CIN L33119UR1981PLC006092 | Active | 14 Sep 1981 | Haridwar, Uttarakhand | ₹7.1 Cr | 10 | View details |
Products & Services of Desh Rakshak
Desh Rakshak offers a comprehensive portfolio of products and services, including Ayurvedic Granules and Syrups and Tablets.
Granules are manufactured and distributed for various health applications using natural ingredients.
Syrups and tablets are produced and supplied for addressing common ailments through Ayurvedic formulations.
Board of directors of Desh Rakshak Aushdhalaya Limited (Desh Rakshak)
Desh Rakshak Aushdhalaya Limited is the primary company behind Desh Rakshak. The board of Desh Rakshak Aushdhalaya Limited currently have 8 directors; the longest-serving is Tosh Kumar Jain, appointed in 1988. 20 earlier directors have ceased.
| Director | Designation | Appointed | Tenure | Entity |
|---|---|---|---|---|
| Tosh Kumar Jain DIN 01540363 | Managing Director | 02 Sep 1988 | 38 yrs 2 mo | Desh Rakshak Aushdhalaya Limited |
| Amit Kumar Singh DIN 07906593 | CFO | 29 May 2017 | 9 yrs 5 mo | Desh Rakshak Aushdhalaya Limited |
| Sohini Bansal DIN 09822553 | Company Secretary | 08 Jan 2022 | 4 yrs 10 mo | Desh Rakshak Aushdhalaya Limited |
| Shruti Gupta DIN 09818957 | Director | 16 Dec 2022 | 3 yrs 10 mo | Desh Rakshak Aushdhalaya Limited |
| Arihant Kumar Jain DIN 06401053 | Whole-time director | 30 Sep 2024 | 2 yrs 1 mo | Desh Rakshak Aushdhalaya Limited |
| Monika Jain DIN 03403491 | Whole-time director | 30 Sep 2024 | 2 yrs 1 mo | Desh Rakshak Aushdhalaya Limited |
| Rajesh Kumar Gupta DIN 01048355 | Director | 13 Aug 2025 | 1 yr 2 mo | Desh Rakshak Aushdhalaya Limited |
| Cheena Golani DIN 11220936 | Director | 30 Dec 2025 | 10 mo | Desh Rakshak Aushdhalaya Limited |
IPO & Listings of Desh Rakshak
Desh Rakshak is a publicly listed company on the BSE with ticker symbol DESHRAK in India, operating in the Health technology sector. As a publicly traded entity, the company provides investors with opportunities to participate in its growth story through equity ownership. The listing enables access to capital markets, enhances corporate visibility, and provides liquidity for shareholders while maintaining transparency through regulatory compliance and regular financial disclosures.
- IPO date14 Dec 1995
- Listed onBSE: DESHRAK
- Listed entityDesh Rakshak Aushdhalaya Ltd.
- Exchange sectorHealth technology
- ISININE971E01016
- Share price₹24.80 (+5% on the day) · 2026-05-11
- Volume (last session)900
- Analyst consensusNo rating
Financials of Desh Rakshak
Exchange-reported figures of Desh Rakshak Aushdhalaya Limited, the listed company behind Desh Rakshak (BSE: DESHRAK).
Financial Highlights
FY 2025-26 Β· StandaloneRevenue vs Net Profit ₹ Cr
Margin trends
Financial summary ₹ Cr
| Metrics | FY 2025-26 | FY 2024-25 | FY 2023-24 | FY 2022-23 | FY 2021-22 | FY 2020-21 | FY 2019-20 |
|---|---|---|---|---|---|---|---|
| Income statement | |||||||
| Revenue | 7.10 | 6.27 | 6.01 | 6.18 | 6.19 | 6.60 | 5.09 |
| Revenue growth | +13.2% | +4.3% | -2.8% | -0.2% | -6.2% | +29.7% | - |
| EBITDA | 1.38 | 1.25 | 1.29 | 1.35 | 1.20 | 0.97 | 0.79 |
| EBITDA margin | +19.4% | +19.9% | +21.5% | +21.8% | +19.4% | +14.7% | +15.5% |
| Profit before tax | 0.67 | 0.55 | 0.50 | 0.49 | 0.57 | 0.57 | 0.37 |
| Net profit | 0.56 | 0.46 | 0.42 | 0.47 | 0.48 | 0.44 | 0.30 |
| Net profit margin | +7.9% | +7.3% | +7.0% | +7.6% | +7.8% | +6.7% | +5.9% |
| EPS (βΉ) | 0.99 | 1.02 | 0.92 | 0.87 | 1.03 | 0.90 | 0.65 |
| Balance sheet | |||||||
| Total assets | 16.53 | 13.04 | 12.31 | 13.31 | 13.61 | 11.78 | 10.56 |
| Net worth | 13.29 | 9.95 | 9.48 | 9.13 | 9.28 | 8.80 | 8.38 |
| Total debt | 2.80 | 3.04 | 2.78 | 4.10 | 4.31 | 2.90 | 2.03 |
| Cash & bank | 0.15 | 0.07 | 0.14 | 0.05 | 0.23 | 0.59 | 0.22 |
| Net working capital | 6.50 | 3.03 | 1.92 | 2.56 | 3.00 | 2.69 | 2.48 |
| Cash flow | |||||||
| Cash from operations | (1.31) | (0.30) | 1.52 | 0.45 | 0.23 | 0.84 | 0.59 |
| Cash from investing | (1.64) | (0.02) | (0.09) | (0.78) | (1.95) | (1.26) | (1.27) |
| Cash from financing | 3.02 | 0.25 | (1.34) | 0.15 | 1.35 | 0.80 | 0.74 |
| Particulars | Jun 2026 | Mar 2026 | Dec 2025 | Sep 2025 | Jun 2025 | Mar 2025 | Dec 2024 | Sep 2024 |
|---|---|---|---|---|---|---|---|---|
| Revenue | 0.83 | 3.45 | 1.40 | 0.95 | 1.30 | 4.39 | 1.88 | 1.19 |
| Revenue growth (YoY) | -36.2% | -21.4% | -25.5% | -20.2% | +20.4% | - | - | - |
| Other income | 0.00 | 0.01 | 0.00 | 0.00 | 0.00 | 0.01 | 0.02 | 0.00 |
| Total expenses | 0.58 | 2.83 | 1.14 | 0.69 | 1.05 | 3.44 | 1.59 | 0.86 |
| EBITDA | 0.25 | 0.62 | 0.26 | 0.26 | 0.25 | 0.95 | 0.29 | 0.33 |
| EBITDA margin | +30.1% | +18.0% | +18.6% | +27.4% | +19.2% | +21.6% | +15.4% | +27.7% |
| Depreciation | 0.11 | 0.13 | 0.10 | 0.10 | 0.10 | 0.31 | 0.11 | 0.11 |
| Interest | 0.05 | 0.10 | 0.06 | 0.08 | 0.05 | 0.22 | 0.08 | 0.08 |
| Profit before tax | 0.09 | 0.40 | 0.10 | 0.08 | 0.10 | 0.43 | 0.12 | 0.14 |
| Tax | 0.00 | 0.11 | 0.00 | 0.00 | 0.00 | 0.09 | 0.00 | 0.00 |
Financial Statements
| Particulars | Jun 2026 | Mar 2026 | Dec 2025 | Sep 2025 | Jun 2025 | Mar 2025 | Dec 2024 | Sep 2024 |
|---|---|---|---|---|---|---|---|---|
| Revenue | 0.83 | 3.45 | 1.40 | 0.95 | 1.30 | 4.39 | 1.88 | 1.19 |
| Revenue growth (YoY) | -36.2% | -21.4% | -25.5% | -20.2% | +20.4% | - | - | - |
| Other income | 0.00 | 0.01 | 0.00 | 0.00 | 0.00 | 0.01 | 0.02 | 0.00 |
| Total expenses | 0.58 | 2.83 | 1.14 | 0.69 | 1.05 | 3.44 | 1.59 | 0.86 |
| EBITDA | 0.25 | 0.62 | 0.26 | 0.26 | 0.25 | 0.95 | 0.29 | 0.33 |
| EBITDA margin | +30.1% | +18.0% | +18.6% | +27.4% | +19.2% | +21.6% | +15.4% | +27.7% |
| Depreciation | 0.11 | 0.13 | 0.10 | 0.10 | 0.10 | 0.31 | 0.11 | 0.11 |
| Interest | 0.05 | 0.10 | 0.06 | 0.08 | 0.05 | 0.22 | 0.08 | 0.08 |
| Profit before tax | 0.09 | 0.40 | 0.10 | 0.08 | 0.10 | 0.43 | 0.12 | 0.14 |
| Tax | 0.00 | 0.11 | 0.00 | 0.00 | 0.00 | 0.09 | 0.00 | 0.00 |
| Particulars | FY 2025-26 | FY 2024-25 | FY 2023-24 | FY 2022-23 | FY 2021-22 | FY 2020-21 | FY 2019-20 |
|---|---|---|---|---|---|---|---|
| Revenue | 7.10 | 6.27 | 6.01 | 6.18 | 6.19 | 6.60 | 5.09 |
| Revenue growth | +13.2% | +4.3% | -2.8% | -0.2% | -6.2% | +29.7% | - |
| Other income | 0.01 | 0.03 | 0.02 | 0.00 | 0.01 | 0.02 | 0.01 |
| Total expenses | 5.72 | 5.02 | 4.72 | 4.83 | 4.99 | 5.63 | 4.30 |
| Employee cost | 0.00 | 0.97 | 0.83 | 0.84 | 0.97 | 1.02 | 0.87 |
| EBITDA | 1.38 | 1.25 | 1.29 | 1.35 | 1.20 | 0.97 | 0.79 |
| EBITDA margin | +19.4% | +19.9% | +21.5% | +21.8% | +19.4% | +14.7% | +15.5% |
| Depreciation | 0.44 | 0.42 | 0.44 | 0.44 | 0.40 | 0.26 | 0.27 |
| Interest | 0.28 | 0.31 | 0.37 | 0.42 | 0.24 | 0.16 | 0.16 |
| Profit before tax | 0.67 | 0.55 | 0.50 | 0.49 | 0.57 | 0.57 | 0.37 |
| Tax | 0.11 | 0.09 | 0.08 | 0.07 | 0.09 | 0.13 | 0.07 |
| Net profit | 0.56 | 0.46 | 0.42 | 0.47 | 0.48 | 0.44 | 0.30 |
| Net profit margin | +7.9% | +7.3% | +7.0% | +7.6% | +7.8% | +6.7% | +5.9% |
| EPS (βΉ) | 0.99 | 1.02 | 0.92 | 0.87 | 1.03 | 0.90 | 0.65 |
| Particulars | FY 2025-26 | FY 2024-25 | FY 2023-24 | FY 2022-23 | FY 2021-22 | FY 2020-21 | FY 2019-20 |
|---|---|---|---|---|---|---|---|
| Equity & liabilities | |||||||
| Share capital | 5.92 | 4.66 | 4.66 | 4.66 | 4.66 | 4.66 | 4.66 |
| Reserves & surplus | 7.37 | 5.29 | 4.82 | 4.47 | 4.62 | 4.14 | 3.72 |
| Shareholders' funds (net worth) | 13.29 | 9.95 | 9.48 | 9.13 | 9.28 | 8.80 | 8.38 |
| Secured loans | 0.26 | 0.74 | 1.31 | 1.83 | 0.00 | 0.00 | 0.00 |
| Unsecured loans | 2.54 | 2.30 | 1.47 | 2.27 | 4.31 | 2.90 | 2.03 |
| Total debt | 2.80 | 3.04 | 2.78 | 4.10 | 4.31 | 2.90 | 2.03 |
| Total liabilities | 16.53 | 13.04 | 12.31 | 13.31 | 13.61 | 11.78 | 10.56 |
| Assets | |||||||
| Gross block | 14.48 | 13.84 | 13.27 | 13.22 | 12.67 | 11.08 | 9.70 |
| Net block | 8.20 | 7.84 | 7.68 | 8.07 | 7.82 | 6.49 | 5.38 |
| Capital work in progress | 1.39 | 1.87 | 2.37 | 2.37 | 2.37 | 2.37 | 2.37 |
| Investments | 0.05 | 0.05 | 0.05 | 0.05 | 0.05 | 0.05 | 0.12 |
| Inventories | 0.25 | 0.19 | 0.30 | 0.81 | 0.85 | 0.69 | 0.79 |
| Sundry debtors | 9.18 | 7.35 | 5.13 | 3.64 | 3.97 | 3.86 | 3.07 |
| Cash & bank balances | 0.15 | 0.07 | 0.14 | 0.05 | 0.23 | 0.59 | 0.22 |
| Loans & advances | 1.28 | 0.36 | 0.36 | 0.49 | 0.46 | 0.34 | 0.15 |
| Total current assets | 10.86 | 7.97 | 5.93 | 4.99 | 5.51 | 5.48 | 4.23 |
| Total current liabilities | 4.36 | 4.94 | 4.01 | 2.43 | 2.51 | 2.79 | 1.75 |
| Net working capital | 6.50 | 3.03 | 1.92 | 2.56 | 3.00 | 2.69 | 2.48 |
| Total assets | 16.53 | 13.04 | 12.31 | 13.31 | 13.61 | 11.78 | 10.56 |
| Particulars | FY 2025-26 | FY 2024-25 | FY 2023-24 | FY 2022-23 | FY 2021-22 | FY 2020-21 | FY 2019-20 |
|---|---|---|---|---|---|---|---|
| Opening cash | 0.07 | 0.14 | 0.05 | 0.23 | 0.59 | 0.22 | 0.16 |
| Net cash from operating activities | (1.31) | (0.30) | 1.52 | 0.45 | 0.23 | 0.84 | 0.59 |
| Net cash from investing activities | (1.64) | (0.02) | (0.09) | (0.78) | (1.95) | (1.26) | (1.27) |
| Net cash from financing activities | 3.02 | 0.25 | (1.34) | 0.15 | 1.35 | 0.80 | 0.74 |
| Net change in cash | 0.08 | (0.07) | 0.09 | (0.18) | (0.36) | 0.37 | 0.06 |
| Closing cash | 0.15 | 0.07 | 0.14 | 0.05 | 0.23 | 0.59 | 0.22 |
| Particulars | FY 2025-26 | FY 2024-25 | FY 2023-24 | FY 2022-23 | FY 2021-22 | FY 2020-21 | FY 2019-20 |
|---|---|---|---|---|---|---|---|
| Growth | |||||||
| Sales growth | +13.2% | +4.3% | -2.8% | -0.2% | -6.2% | +29.7% | - |
| EBITDA growth | +10.4% | -3.1% | -4.4% | +12.5% | +23.7% | +22.8% | - |
| PBT growth | +21.8% | +10.0% | +2.0% | -14.0% | 0.0% | +54.1% | -11.9% |
| Net income growth | +21.7% | +9.5% | -10.6% | -2.1% | +9.1% | +46.7% | - |
| Revenue CAGR (3Y) | +4.7% | +0.4% | -3.1% | +6.7% | +3.7% | +9.1% | +0.1% |
| EBITDA CAGR (3Y) | +0.7% | +1.4% | +10.0% | +19.6% | +15.0% | +11.5% | +6.2% |
| Profitability & leverage | |||||||
| Net income margin | +7.9% | +7.3% | +7.0% | +6.8% | +7.8% | +6.7% | +5.9% |
| Return on capital employed | - | +7.0% | +6.9% | +7.1% | +6.4% | +6.4% | +5.2% |
| Return on net worth | - | +5.0% | +4.7% | +5.0% | +5.4% | +4.9% | +3.6% |
| Debt / equity | - | 0.30 | 0.37 | 0.46 | 0.40 | 0.29 | 0.20 |
| Long-term debt / equity | - | 0.30 | 0.37 | 0.46 | 0.40 | 0.29 | 0.20 |
| Interest cover | 29.79 | 37.35 | 43.53 | 46.15 | 30.00 | 22.54 | 30.77 |
| Efficiency & per share | |||||||
| Fixed asset turnover | - | 0.46 | 0.46 | 0.48 | 0.52 | 0.64 | 0.56 |
| Inventory turnover | - | 25.59 | 10.83 | 7.45 | 8.04 | 8.92 | 6.02 |
| Debtors turnover | - | 1.00 | 1.37 | 1.62 | 1.58 | 1.90 | 1.69 |
| EPS (βΉ) | 0.99 | 1.02 | 0.92 | 0.87 | 1.03 | 0.90 | 0.65 |
| Dividend per share (βΉ) | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Book value per share (βΉ) | 0.00 | 21.23 | 20.21 | 19.46 | 19.78 | 18.75 | 17.85 |
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track β from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Related news about Desh Rakshak
Complete news archive for Desh Rakshak
Full article history, source details, and older brand coverage require an active premium plan.
- Full article archive
- Source and publication date
- Older coverage
- Brand-specific news history
Verified entity values are shown only after access is granted.
Frequently Asked Questions about Desh Rakshak
Desh Rakshak is headquartered in India.
The primary company behind Desh Rakshak, Desh Rakshak Aushdhalaya Limited, reported revenue of βΉ7.11 Cr for FY 2026, up 13% year on year.
Desh Rakshak is recognized as an established Ayurvedic brand that has been operated since 1901, offering a range of herbal products including granules, balms, tablets, and syrups. It is situated in Haridwar, India, where manufacturing and distribution processes are managed for both domestic and export markets. Products are supplied to government departments and individual customers, with quality ensured through natural ingredients and customer feedback. The company is noted for its historical significance in the region and commitment to Ayurvedic traditions, as evidenced by testimonials and online presence.
Desh Rakshak offers Ayurvedic Granules and Syrups and Tablets.
Yes, Desh Rakshak is publicly traded on BSE under the ticker symbol DESHRAK.
Desh Rakshak operates through Desh Rakshak Aushdhalaya Limited.
The legal entities of Desh Rakshak currently have 8 directors, including Tosh Kumar Jain, Amit Kumar Singh, Shruti Gupta and others.

